Aquinox Pharmaceuticals Company Profile (NASDAQ:AQXP)

About Aquinox Pharmaceuticals

Aquinox Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company discovering and developing targeted therapeutics in disease areas of inflammation and immuno-oncology. The Company operates in the segment of identification and development of therapeutics in disease areas of inflammation and immuno-oncology. Its primary focus is anti-inflammatory product candidates targeting the Src Homology 2 (SH2)-containing inositol-5-phosphatase 1 (SHIP1) enzyme, which is a regulator of a cellular signaling pathway in immune cells. The Company's product candidate, AQX-1125, is a small molecule activator of SHIP1 suitable for oral, once daily dosing. The Company is developing AQX-1125 as a treatment in interstitial cystitis/bladder pain syndrome (IC/BPS), a chronic inflammatory disease of the bladder. It has completed and reported results from its Leadership trial, which is a multicenter, randomized, double-blind, placebo-controlled, Phase II clinical trial.

Industry, Sector and Symbol:

Sector: Medical
Industry: Drugs - Generic
Sub-Industry: N/A
Exchange: NASDAQ
Symbol: AQXP
CUSIP:

Key Metrics:

Previous Close: $13.62
50 Day Moving Average: $11.78
200 Day Moving Average: $8.98
52-Week Range: $6.01 - $16.75
Trailing P/E Ratio: N/A
Foreward P/E Ratio: -6.19
P/E Growth: 0.00
Market Cap: $229.95M
Outstanding Shares: 17,212,000
Beta: -18.91

Profitability:

Return on Equity: -27.16%
Return on Assets: -25.72%

Debt:

Current Ratio: 7.97%
Quick Ratio: 7.97%

Additional Links:

Companies Related to Aquinox Pharmaceuticals:

Consensus Ratings for Aquinox Pharmaceuticals (NASDAQ:AQXP) (?)

Ratings Breakdown:	1 Hold Rating, 5 Buy Ratings
Consensus Rating:	Buy (Score: 2.83)
Consensus Price Target:	$20.33 (52.20% upside)

Analysts' Ratings History for Aquinox Pharmaceuticals (NASDAQ:AQXP)

Show:

Date	Firm	Action	Rating	Price Target
8/17/2016	Canaccord Genuity	Reiterated Rating	Buy	$22.00
8/5/2016	Jefferies Group	Boost Price Target	Hold	$7.00 -> $9.00
5/12/2016	Needham & Company LLC	Initiated Coverage	Buy	$25.00
3/16/2016	Leerink Swann	Lower Price Target	Outperform	$26.00 -> $21.00
11/3/2015	Cowen and Company	Reiterated Rating	Buy	$23.00
10/6/2015	Guggenheim	Initiated Coverage	Buy	$22.00

(Data available from 10/1/2014 forward)

Earnings History for Aquinox Pharmaceuticals (NASDAQ:AQXP)

Date	Quarter	Consensus Estimate	Actual EPS	Release Link	Conference Call
11/8/2016
8/4/2016	Q2	($0.41)	($0.63)	View	N/A
5/10/2016	Q1	($0.35)	($0.39)	View	N/A
3/14/2016	Q4	($0.37)	($0.26)	View	N/A
11/10/2015	Q315	($0.45)	($0.43)	View	N/A
8/6/2015	Q215	($0.56)	($0.44)	View	N/A
5/12/2015	Q115	($0.83)	($0.60)	View	N/A
4/15/2015		($0.57)	($0.78)	View	N/A
3/16/2015		($0.76)	($0.78)	View	N/A
11/4/2014		($0.29)	($0.59)	View	N/A
8/11/2014		($0.27)	($0.51)	View	N/A

(Data available from 1/1/2011 forward)

Earnings Estimates for Aquinox Pharmaceuticals (NASDAQ:AQXP)

Current Year EPS Consensus Estimate: $-2.31 EPS
Next Year EPS Consensus Estimate: $-2.16 EPS

Quarter	Number of Estimates	Low Estimate	High Estimate	Average Estimate
Q1 2016	2	($0.38)	($0.31)	($0.35)
Q2 2016	2	($0.47)	($0.42)	($0.45)
Q3 2016	2	($0.53)	($0.45)	($0.49)
Q4 2016	2	($0.59)	($0.49)	($0.54)

(Data provided by Zacks Investment Research)

Dividend History for Aquinox Pharmaceuticals (NASDAQ:AQXP)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Aquinox Pharmaceuticals (NASDAQ:AQXP)

Insider Ownership Percentage: 3.00%
Institutional Ownership Percentage: 89.41%

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
9/20/2016	Bros. Advisors Lp Baker	Major Shareholder	Buy	2,783,605	$12.25	$34,099,161.25
3/16/2016	Bros. Advisors Lp Baker	Major Shareholder	Buy	471,667	$7.99	$3,768,619.33
3/15/2016	Bros. Advisors Lp Baker	Major Shareholder	Buy	109,912	$7.98	$877,097.76
1/26/2016	Bros. Advisors Lp Baker	Major Shareholder	Buy	140,786	$10.80	$1,520,488.80
1/20/2016	Bros. Advisors Lp Baker	Major Shareholder	Buy	112,034	$9.48	$1,062,082.32
1/19/2016	Bros. Advisors Lp Baker	Major Shareholder	Buy	78,045	$9.11	$710,989.95
1/15/2016	Bros. Advisors Lp Baker	Major Shareholder	Buy	202,623	$8.28	$1,677,718.44
9/10/2015	Bros. Advisors Lp Baker	Major Shareholder	Buy	2,480,032	$15.50	$38,440,496.00
8/24/2015	David Chilton Mitchell	VP	Buy	3,575	$17.81	$63,670.75
8/12/2015	Kamran Alam	CFO	Sell	29,079	$18.67	$542,904.93
8/12/2015	Lloyd Mackenzie	VP	Sell	35,887	$18.67	$670,010.29
12/17/2014	& Johnson Johnson	Major Shareholder	Sell	8,100	$7.62	$61,722.00
12/12/2014	& Johnson Johnson	Major Shareholder	Sell	5,000	$7.51	$37,550.00
12/10/2014	& Johnson Johnson	Major Shareholder	Sell	8,300	$7.72	$64,076.00
12/9/2014	& Johnson Johnson	Major Shareholder	Sell	5,000	$7.73	$38,650.00
12/8/2014	& Johnson Johnson	Major Shareholder	Sell	2,000	$7.69	$15,380.00
12/5/2014	& Johnson Johnson	Major Shareholder	Sell	15,900	$7.76	$123,384.00
12/1/2014	& Johnson Johnson	Major Shareholder	Sell	1,200	$7.54	$9,048.00
11/26/2014	& Johnson Johnson	Major Shareholder	Sell	2,000	$7.75	$15,500.00
11/24/2014	& Johnson Johnson	Major Shareholder	Sell	9,500	$8.14	$77,330.00
3/12/2014	Pfizer Inc	Major Shareholder	Buy	272,727	$11.00	$2,999,997.00

(Data available from 1/1/2013 forward)

Latest Headlines for Aquinox Pharmaceuticals (NASDAQ:AQXP)

Date	Headline
	What are Brokerage Firms Saying About Aquinox Pharmaceuticals ... - Frisco Fastball (NASDAQ:AQXP) friscofastball.com - September 30 at 8:47 AM
	New Analyst Ratings On Aquinox Pharmaceuticals, Inc. (AQXP ... - NewsDen (NASDAQ:AQXP) newsden.net - September 29 at 8:21 AM
	Latest Analyst Ratings For Aquinox Pharmaceuticals, Inc. (AQXP) - The De Soto Edge (NASDAQ:AQXP) desotoedge.com - September 29 at 8:21 AM
	Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) Looks Strong Ahead Of Phase III Completion - Street Register (NASDAQ:AQXP) streetregister.com - September 28 at 8:21 AM
	Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) Looks Strong Ahead Of Phase III Completion (NASDAQ:AQXP) streetregister.com - September 27 at 8:00 AM
	[$$] Two Cancer Biotechs See Bullish Insider Buying (NASDAQ:AQXP) www.barrons.com - September 27 at 8:00 AM
	Aquinox Announces Closing of $75.4 Million Public Offering of Common (NASDAQ:AQXP) www.nasdaq.com - September 24 at 8:52 AM
	Aquinox Announces Closing of $75.4 Million Public Offering of Common Stock, Including Full Exercise (NASDAQ:AQXP) m.nasdaq.com - September 24 at 8:52 AM
	Aquinox Announces Closing of $75.4 Million Public Offering of Common Stock, Including Full Exercise of Underwriters ... - Nasdaq (NASDAQ:AQXP) www.nasdaq.com - September 23 at 3:58 PM
	Aquinox Announces Closing of $75.4 Million Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares (NASDAQ:AQXP) finance.yahoo.com - September 23 at 3:58 PM
	Aquinox Pharmaceuticals Announces $65 Million Public Offering of Common Stock (NASDAQ:AQXP) www.bctechnology.com - September 22 at 3:31 PM
	Aquinox Pharmaceuticals Inc (AQXP): Baker Bros. Advisors Pushes Stake to Over 45% (NASDAQ:AQXP) www.insidermonkey.com - September 22 at 3:31 PM
	Aquinox Pharmaceuticals : Prices Public Offering of Common Stock (NASDAQ:AQXP) www.4-traders.com - September 22 at 9:26 AM
	Aquinox Pharmaceuticals Coverage Initiated at Guggenheim (AQXP) - Petro Global News 24 (NASDAQ:AQXP) petroglobalnews24.com - September 21 at 4:28 PM
	AQUINOX PHARMACEUTICALS, INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events, Financial (NASDAQ:AQXP) biz.yahoo.com - September 21 at 8:41 AM
	[Stock]'s Company Shares [IncreasedDecreased] [IncreaseDecrease] After [HighLow] Volatility - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - September 20 at 3:34 PM
	Aquinox Pharma (AQXP) Plans Common Stock Offering (NASDAQ:AQXP) www.streetinsider.com - September 20 at 9:30 AM
	Aquinox Prices Public Offering of Common Stock (NASDAQ:AQXP) www.marketwatch.com - September 20 at 9:30 AM
	Aquinox Pharmaceuticals : Announces Proposed Public Offering of Common Stock (NASDAQ:AQXP) www.4-traders.com - September 20 at 9:30 AM
	Aquinox Pharma (AQXP) Plans Common Stock Offering - StreetInsider.com (NASDAQ:AQXP) www.streetinsider.com - September 19 at 4:30 PM
	Aquinox Pharmaceuticals Announces Proposed Public Offering of Common Stock (NASDAQ:AQXP) finance.yahoo.com - September 19 at 4:30 PM
	Aquinox Pharmaceuticals (AQXP) is in Overbought Territory: What's Next? (NASDAQ:AQXP) finance.yahoo.com - September 16 at 12:14 PM
	Investor Scope: Checking in on Shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - September 14 at 8:04 AM
	Market Focus: Checking on Session Activity for Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Shares - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - September 12 at 3:33 PM
	Analysts Place Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Under the Lens of the Microscope - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - September 12 at 8:21 AM
	Ra Capital Management buys $15752306 stake in Aquinox Pharmaceuticals Inc (AQXP) - National Daily Press (NASDAQ:AQXP) www.nationaldailypress.com - September 12 at 8:21 AM
	Market Review: Watching Session Activity of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Shares - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - September 9 at 3:31 PM
	Stock Perspective: Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Earnings in View - Frisco Fastball (NASDAQ:AQXP) friscofastball.com - September 8 at 10:43 AM
	Trading Update: Following Activity of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Shares During the Current Session - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - September 7 at 3:32 PM
	Stock Showing Gains in Today's Session: Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - September 7 at 3:32 PM
	Aquinox Pharma (AQXP) Commences Dosing in AQX-1125 PHase 3 as IC/BPS Treatment - StreetInsider.com (NASDAQ:AQXP) www.streetinsider.com - September 6 at 3:31 PM
	Investor Beat: Watching Activity of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Shares During the Session - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - September 3 at 8:23 AM
	Expert Analysts Position for: Gold Fields Limited (NYSE:GFI) , Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Wall Street Times (press release) (NASDAQ:AQXP) www.wallstreetnews24.com - September 2 at 8:13 AM
	Stock Ticking Higher in Trading: Aquinox Pharmaceuticals Inc. (NASDAQ:AQXP) - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - September 1 at 3:33 PM
	Market Checkup: Performance Review on Shares of Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - August 31 at 3:33 PM
	How is the Crowd Rating Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) Shares? - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - August 30 at 10:55 AM
	Analyst Rating Update on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - August 23 at 3:35 PM
	Stock Analyst Estimates on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Post News (NASDAQ:AQXP) www.kentuckypostnews.com - August 19 at 11:57 AM
	Edited Transcript of AQXP earnings conference call or presentation 4-Aug-16 8:30pm GMT (NASDAQ:AQXP) finance.yahoo.com - August 12 at 9:00 PM
	AQUINOX PHARMACEUTICALS, INC Financials (NASDAQ:AQXP) finance.yahoo.com - August 12 at 3:43 PM
	Stock Gaps Down Summary – QVCB, AQXP, FLDM, FTD, CPSI, SWIR, HDP, FEYE (NASDAQ:AQXP) www.fxpips.com - August 8 at 8:21 AM
	Aquinox Pharmaceuticals Announces Second Quarter 2016 Financial Results - GlobeNewswire (press release) (NASDAQ:AQXP) globenewswire.com - August 5 at 11:58 AM
	Aquinox reports 2Q loss (NASDAQ:AQXP) sg.finance.yahoo.com - August 5 at 11:58 AM
	5:25 pm Aquinox Pharma reports Q2; on track to initiate enrollment in Phase 3 clinical trial with AQX-1125 in interstitial cystitis/bladder pain syndrome (IC/BPS) this quarter (NASDAQ:AQXP) finance.yahoo.com - August 4 at 9:18 PM
	Q2 2016 Aquinox Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:AQXP) biz.yahoo.com - August 4 at 12:04 PM
	Aquinox to Present at Canaccord Genuity 36th Annual Growth Conference (NASDAQ:AQXP) www.pharmiweb.com - August 2 at 3:34 PM
	Aquinox Pharmaceuticals to Announce Second Quarter 2016 Financial Results - PharmiWeb.com (press release) (NASDAQ:AQXP) www.pharmiweb.com - August 2 at 8:22 AM
	Aquinox Pharmaceuticals to Announce Second Quarter 2016 Financial Results (NASDAQ:AQXP) www.publicnow.com - August 1 at 3:33 PM
	Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP): A Quick Review & Update - Press Telegraph (NASDAQ:AQXP) presstelegraph.com - July 23 at 3:31 PM
	Equity Roundup: Stock Performance Focus on Aquinox Pharmaceuticals, Inc. (NASDAQ:AQXP) - Press Telegraph (NASDAQ:AQXP) presstelegraph.com - July 23 at 6:48 AM